To make trials more efficient and ensure compliance, syneed medidata GmbH, an independent CRO in Germany, has signed a Master Services Agreement with Boston’s AG Mednet....

Improved quality-control measures in clinical trials are gaining traction. AG Mednet driven by its mission of quality at the source for image-intensive trials helps sponsors and core labs comply with the FDA’s newly stated guidance. ...

AG Mednet’s Submission Quality & Compliance software was recently named a finalist for the Massachusetts Technology Leadership Council’s 2013 Innovative Technology of the Year for Healthcare/Life Sciences. The award was announced before a crowd of more than 200 tech executives at the Microsoft NERD Center...

On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape. Among the clinical trial...

AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance software, MDHVC is strengthening its commitment to quality in multi-center...

Founder, President and CEO of AG Mednet, honored as one of 20 innovators changing the face of the clinical trial industry by The CenterWatch Monthly The CenterWatch Monthly – one of the nation’s leading pharmaceutical and clinical trial industry publications – has selected Boston’s Abraham Gutman...

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet today announced the signing of a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL). As the adoption of Asia and Japan-specific clinical trials continues to grow,...

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet, Inc. has licensed from...

AG Mednet, Inc. today announced that it has signed an OEM agreement with ICON Medical Imaging, a division of ICON plc, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into ICON’s imaging trial offerings. AG Mednet provides the quality assurance and...

More than half of all image-related clinical trial query stoppages result from preventable human errors, according to industry research. In response, AG Mednet announces its “Submission Quality & Compliance” module that delivers a new layer of automated quality assurance to reduce submission error rates and...